In this interview with Andrew Kleuss on Investors Hub, Vitaliy makes the case that concerns over Amazon’s entry into the pharmaceuticals business are probably overblown. To parse this problem, Vitaliy differentiates between pharmacies and drug distributors, and analyzes the extent to which Amazon can compete with both. While Amazon might place some pressure on pharmacies over time, he explains how drug distributors’ unique supply chains should remain robust against a competitive threat from Amazon.
Enjoyed this read?
Share it with someone who’d love it too!
New to investing?
Explore these valuable guides to get started.
Related Articles
Today’s Market = 1999 Capex + 2008 Credit – Ep 298
Anthropic’s revenue has grown nearly 10x a year, three years running. Its losses are accelerating with it. And here ... Read more
You Don’t Need to Be an Expert to Hire One. You Need a Tunaman. – Ep 297
My wife and I are taking a perfectly good 25-year-old house and spending 20% of the purchase price on ... Read more
Most People Don’t Want to Write. They Want to Have Written. – Ep 296
I was at a conference in Switzerland. A reader came up to me and asked, "Vitaliy, I've been reading your articles for years. I'd like to write. How should I start?"
You are not as smart as you think you are – Ep 295
Lately, I’ve been getting this powerful feeling that everything I touch turns to gold. Every time I buy a ... Read more
comments
0